[489] SERUM HEPATITIS B SURFACE ANTIGEN (HBsAg) LEVEL CAN REFLECT HEPATITIS B VIRUS IN THE LIVER AND PREDICT TREATMENT RESPONSE von Chan, H.L.Y, Wong, V.W.S, Tse, A.M.L, Tse, C.H, Chim, A.M.L, Chan, H.Y, Wong, G.L.H, Sung, J.J.Y

Volltext

[519] RAPID VIRAL SUPPRESSION CAN PREDICT SUSTAINED VIROLOGICAL RESPONSE TO PEGINTERFERON AND LAMIVUDINE COMBINATION TREATMENT IN CHRONIC HEPATITIS B von Sung, J.J.Y, Wong, B.W.S, Chim, A.M.L, Chan, H.Y, Hui, A.Y, Wong, G.L.H, Choi, C.L, Chan, H.L.Y

Volltext

487 Interleukin-1-beta gene polymorphism is associated with sustained response to anti-viral treatment in chronic hepatitis B von Chan, H.L.Y., Tse, A.M.L., Zhan, M.D., Wong, V.W.S., Chim, A.M.L., Hui, A.Y., Sung, J.J.Y.

Volltext

488 Virodynamic predictors of treatment response to peginterferon and lamivudine combination treatment of HBeA-positive chronic hepatitis B von Chan, H.L.Y., Mihm, U., Zeuzem, S., Chim, A.M.L., Hui, A.Y, Wong, V.W.S., Sung, J.J.Y., Herrmann, E.

Volltext

423 A randomized trial of peginteferon alfa-2B and lamivudine combination treatment versus lamivudine monotherapy in Chinese patients with HBEAG-positive chronic hepatitis B von Chan, H.L.Y., Leung, N.W.Y., Hui, A.Y., Liew, C.T., Chim, A.M.L., Chan, F.K.L., Hung, L.C.T., Sung, J.J.Y.

Volltext

Combination of pegylated interferon and lamivudine is superior to lamivudine monotherapy in the treatment of chronic hepatitis B — a randomized trial von Sung, J.J.Y., Chan, H.L.Y., Hui, A.Y., Chan, F.K.L., Chim, A.M.L., Wong, M.L., Leung, N.W.Y.

Volltext